MF variantCTCL Β· LocalisedICD-10 C84.4

Pagetoid reticulosis

Woringer-Kolopp disease Β· localised pagetoid reticulosis Β· Ketron-Goodman (disseminated)

Pagetoid reticulosis is a rare WHO-recognised localised variant of mycosis fungoides characterised by a solitary, slowly progressive, well-demarcated psoriasiform or verrucous plaque, usually on an acral / extensor distal extremity. Histology shows striking epidermotropism of atypical lymphocytes ("pagetoid" pattern, resembling Paget cells). The localised Woringer-Kolopp form has an indolent course and excellent prognosis; the disseminated Ketron-Goodman variant is now considered classical MF / aggressive CTCL.

CurrentLast reviewed 16 May 2026

Pathogenesis and classification

  • Clonal T-cell proliferation with marked epidermotropism.
  • Woringer-Kolopp (localised): solitary, indolent; CD4+ or CD8+; some CD30+.
  • Ketron-Goodman (disseminated): now considered aggressive CTCL, classical MF, or CD8+ aggressive epidermotropic CTCL β€” not a true PR variant.
  • WHO-HAEM5 classifies localised pagetoid reticulosis as a MF variant.

Clinical features

  • Solitary, slowly progressive (years) well-demarcated, red-brown or pink-grey, psoriasiform or verrucous plaque.
  • Site: acral / extensor extremities β€” dorsum hand, foot, knee, elbow, leg.
  • 1-10 cm diameter; occasionally larger.
  • Asymptomatic; rarely pruritic.
  • Prognosis excellent for localised disease; no systemic dissemination reported.

Investigations

  • Skin biopsy: hyperplastic epidermis infiltrated by single and clustered atypical lymphocytes with halo (pagetoid pattern); minimal dermal infiltrate.
  • IHC: CD3+, CD4+ or CD8+ (CD8+ commoner in localised PR); CD30 positive in some; loss of CD7; high Ki-67.
  • TCR gene rearrangement: clonal.
  • Full skin examination and lymph-node palpation (mandatory exclusion of more extensive MF).
  • Bloods: FBC, blood-film flow cytometry (rule out SΓ©zary).

Differentials

  • Classical mycosis fungoides patch / plaque β€” multiple lesions; truncal predominant.
  • Bowen disease (cSCC in situ) β€” keratotic; biopsy + IHC distinguishes.
  • Psoriasis (single plaque), verruca vulgaris, nummular eczema.
  • Squamous cell carcinoma.
  • Lichen simplex chronicus.
  • Pagetoid melanoma / amelanotic melanoma β€” biopsy + melanocytic IHC excludes.

Management

  • Localised radiotherapy β€” first-line for Woringer-Kolopp; typically 20-30 Gy.
  • Surgical excision for small accessible lesions.
  • Topical: super-potent corticosteroids; topical mechlorethamine; imiquimod (limited evidence).
  • Long-term dermatology follow-up given small risk of evolution.
  • Counsel about excellent prognosis with localised disease.

References

  1. Woringer F, Kolopp P. Lésion erythemato-squameuse polycyclique de l'avant-bras évoluant depuis 6 ans chez un garçonnet de 13 ans. Ann Dermatol Syphiligr. 1939;10:945-958.
  2. Haghighi B et al. Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol. 2000;13:502-510.
  3. Willemze R et al. The 2018 WHO-EORTC classification of cutaneous lymphomas. Blood. 2019;133:1703-1714.
  4. Gilson D et al. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. Br J Dermatol; 2019;180:496-526.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.